Skip directly to page options Skip directly to A-Z link
Volume 23, Number 11—November 2017
Dispatch

Emergence of Bordetella holmesii as a Causative Agent of Whooping Cough, Barcelona, Spain

Alba Mir-Cros, Gema Codina, M. Teresa Martín-Gómez, Anna FàbregaComments to Author , Xavier Martínez, Mireia Jané, Diego Van Esso, Thais Cornejo, Carlos Rodrigo, Magda Campins, Tomàs Pumarola, and Juan José González-LópezComments to Author 
Author affiliations: Hospital Universitari Vall d’Hebron, Barcelona, Spain (A. Mir-Cros, G. Codina, M.T. Martín-Gómez, A. Fàbrega, X. Martínez, T. Cornejo, C. Rodrigo, M. Campins, T. Pumarola, J.J. González-López); Universitat Autònoma de Barcelona, Barcelona (A. Mir-Cros, G. Codina, C. Rodrigo, M. Campins, T. Pumarola, J.J. González-López); Public Health Agency of Catalonia, Barcelona (M. Jané); Primary Care Health Centre Service ‘Muntanya,’ Barcelona (D. Van Esso)

Main Article

Table 2

Comparison of demographic, vaccination-related, clinical characteristics between patients with Bordetella pertussis and B. holmesii infection, Hospital Vall d’Hebron, Barcelona, Spain, 2015–2016*

Characteristic
 B. pertussis, n = 40
 B. holmesii, n = 10
 p value
Median age (range), y 5.5 (0.08–74) 9 (4–40) 0.07
Median pertussis vaccine doses received (range) 4 (0–5) 5 (3–5) 0.21
Median time from last pertussis vaccine dose received to date of diagnosis (range), y 1.92 (0.08–11.70) 3.82 (1.03–14.05) 0.1
Fever, no. (%) 5 (12.5) 1 (10) 1
Whoop, no. (%) 9 (22.5) 1 (10) 0.66
Paroxysms, no. (%) 4 (10) 1 (10) 1
Cough ≥14 d, no. (%) 12 (30) 4 (40) 0.7
Hospitalized, no. (%) 4 (10) 0 0.57

*Differences were assessed for significance using the chi-squared exact test (in comparison with independent qualitative variables) and the Mann-Whitney U-test (for quantitative variables; no normality was observed in data distribution). We selected a randomized sample of confirmed B. pertussis cases with a 4:1 relation with B. holmesii–infected patients as a comparison group. p values <0.05 were considered statistically significant at the 95%
CI level.

Main Article

Page created: October 17, 2017
Page updated: October 17, 2017
Page reviewed: October 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external